IDiyas

For the Inventor, By the Inventor

Funabashi, Japan

Hiroshi Iwasaki

USPTO Granted Patents = 15

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 180(Granted Patents)


Company Filing History:

goldMedal15 out of 1,235 
 
Nissan Chemical Industries Limited
 patents

Years Active: 1990-1999

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5872130 - Quinoline type mevalonoactones (1999-02-16),
2. 5856336 - Quinoline type mevalonolactones (1999-01-05),
3. 5854259 - Quinoline type mevalonolactones (1998-12-29),
4. 5514804 - Diastereomer salt of optically active quinolinemevalonic acid (1996-05-07),
5. 5473075 - Diastereomer salt of optically active quinolinemevalonic acid (1995-12-05),
6. 5284953 - Diastereomer salt of optically active quinolinemevalonic acid (1994-02-08),
7. 5185328 - Quinoline type mevalonolactones useful for treating hyperlipidemia, (1993-02-09),
8. 5137891 - 2',3' cyclic fused pyrazolopyrimidine type mevalonolactones (1992-08-11),
9. 5102888 - Quinoline type mevalonolactones useful for treating hyperlipidemia and (1992-04-07),
10. 5055472 - Pyrazolopyrimidine type mevalonolactones (1991-10-08),
11. 5026708 - Pyrimidine type mevalonolactones (1991-06-25),
12. 5026698 - Thienopyridine type mevalonolactones (1991-06-25),
13. 5024999 - Pyrazolopyridine type mevalonolactones useful as pharmaeuticals (1991-06-18),
14. 5011930 - Quinoline type mevalonolactones (1991-04-30),
15. 4977161 - Isoxazolopyridine type mevalonolactones (1990-12-11),

Title: Hiroshi Iwasaki: Innovator in Pharmaceutical Chemistry

Introduction

Hiroshi Iwasaki is a notable inventor based in Funabashi, Japan, recognized for his significant contributions to the field of pharmaceutical chemistry. With an impressive repertoire of 15 patents, Iwasaki has made advancements primarily related to compounds that affect cholesterol biosynthesis. His latest innovations showcase his expertise and commitment to developing effective medical therapies.

Latest Patents

Among Iwasaki's recent patents are the quinoline type mevalonolactones, which are derivatives featuring a quinoline ring structure. These compounds are engineered to have HMG-CoA inhibiting effects, which are key in combating conditions like hyperlipidemia, hyperlipoproteinemia, and atherosclerosis. Specifically, one of his formulations includes a compound with a structure described as Z=--CH(OH)--CH.sub.2--CH(OH)--CH.sub.2--COO.1/2Ca, aiming to provide pharmaceutical solutions for cholesterol-related disorders.

Career Highlights

Iwasaki works with Nissan Chemical Industries Limited, a company renowned for its focus on chemical innovation and research. His position reflects his capability to spearhead research initiatives that combine cutting-edge chemistry with practical applications in medicine. The impact of his work continues to be profound in the pharmaceutical landscape.

Collaborations

In his career, Hiroshi Iwasaki has collaborated with esteemed colleagues such as Mikio Suzuki and Mitsuaki Sakashita. These partnerships have facilitated a rich exchange of ideas and knowledge, contributing to the overall advancement of their shared projects and leading to impactful innovations in the industry.

Conclusion

Hiroshi Iwasaki exemplifies the drive and ingenuity of contemporary inventors in the pharmaceutical field. Through his patents, particularly those related to quinoline-based compounds, he has positioned himself as a key player in the fight against cholesterol-related health issues. His continued work at Nissan Chemical Industries Limited promises to drive future innovations that can improve the quality of life for many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…